United States · FDA National Drug Code directory
Valsartan and Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65162-847_e40f4475-c8d3-48a6-913f-cf7c8c7b119b
- Product NDC
- 65162-847
- Form
- TABLET, FILM COATED
- Composition / generic term
- Valsartan and Hydrochlorothiazide
- Labeler
- Amneal Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230814
- Source listing expiry
- 20261231
Source-listed ingredients
- VALSARTAN — 160 mg/1
- HYDROCHLOROTHIAZIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (65162-847-03) · 65162-847-03
- 90 TABLET, FILM COATED in 1 BOTTLE (65162-847-09) · 65162-847-09
- 1000 TABLET, FILM COATED in 1 BOTTLE (65162-847-11) · 65162-847-11
- 500 TABLET, FILM COATED in 1 BOTTLE (65162-847-50) · 65162-847-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →